BURLINGTON, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...

Kiniksa has interacted with the U.S. Food and Drug Administration (FDA) and expects to initiate a Phase 2/3 clinical trial of ...

Dr Reddy's Laboratories Ltd said on February 25 that the American drugs regulator finished inspecting its API manufacturing ...

Initial feasibility study of its soluble, Ph neutral, fast acting granular or powder drug delivery system is completeTest results support the next development step with Phase 1clinical trial expected ...

Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...

The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable semaglutide, the active ingredient in weight loss juggernauts Wegovy and ...

THAI firms grappling with losses of about US$60 million from China’s ban on sugar syrup face shutdowns as soon as next month, ...

A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.

For any company developing AI-powered solutions, the “why” should guide every decision. The technical sophistication of your ...